Rallybio (RLYB)

• Market cap: $32.9M
• 1 day: 8.34%
• 5 days: 4.9%
• 1 month: 24.17%
• 3 months: 29.81%
• 6 months: 138.52%
• Year to date: -18.14%
• 1 year: -20.32%
• 5 years: -94.48%
• 10 years: -94.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Employees: 15